The Assisted Reproductive Technology Market refers to medical procedures and products used to treat infertility, including IVF and artificial insemination. This market is expanding quickly due to rising infertility rates, delayed parenthood, lifestyle changes, and increasing acceptance of fertility treatments worldwide. According to industry estimates, the global assisted reproductive technology market size was USD 25.07 Billion in 2025 and is projected to reach USD 47.06 Billion by 2035, growing at a CAGR of 6.50% from 2026 to 2035.

How Big Is the Assisted Reproductive Technology Market and What Are the Key Trends?

The Assisted Reproductive Technology Market is witnessing strong demand driven by technological advancements such as embryo freezing, genetic screening, and improved success rates. Rising awareness, supportive government initiatives, and growth in medical tourism—especially in Asia Pacific—are also shaping market trends. Increased use of frozen embryo replacement (FER) and donor programs is further accelerating growth.

What Are the Major Segments in the Assisted Reproductive Technology Market?

By type outlook, In-Vitro Fertilization (IVF) dominates the market, including fresh and frozen donor and non-donor cycles. Artificial insemination methods such as intrauterine and intracervical insemination also hold a significant share. By product, accessories & disposables lead due to their repeated usage, followed by instruments and reagents & media.

Request sample report Explore

Which Age Group and Applications Drive Market Demand?

Women older than age 35 represent a major consumer group due to declining fertility rates, while women under 35 show higher treatment success rates. Key applications include Frozen Embryo Replacement (FER), surrogacy, and ovulation induction. Fertility clinics remain the primary end users, followed by hospitals and other healthcare facilities.

Which Regions and Companies Are Leading the Assisted Reproductive Technology Market?

North America leads due to advanced healthcare infrastructure, followed by Europe. Asia Pacific is the fastest-growing region because of cost-effective treatments and increasing infertility awareness. Key companies include Merck KGaA, Vitrolife AB, CooperSurgical, Inc., FUJIFILM Irvine Scientific, and European Sperm Bank, among others.